Navigation bar
  Print document Start Previous page
 134 of 221 
Next page End  

treatment of mania The Depakote Mania Study Group. JAMA 1994; 271:918.
Calabrese JR, Markovitz P, Kimmel SE, et al. Spectrum of efficacy of valproate in 78 rapid-cycling
bipolar patients. J Clin Psychopharmacol 1992; 12(suppl):53.
Swann AC, Bowden CL, Calabrese JR, et al. Differential effect of number of previous episodes of
affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 1999; 156:1264.
Swann AC, Bowden CL, Morris D, et al. Depression during mania. Treatment response to lithium or
divalproex. Arch Gen Psychiatry 1997; 54:37.
Побочные и токсические эффекты
Dreifuss FE. Valproic acid hepatic fatalities: revised table. Neurology 1989; 39:1558.
Dreifuss FE, Langer DH, Moline KA, et al. Valproic acid hepatic fatalities. II: U.S. experience since
1984. Neurology 1989; 39:201.
Smith MC, Black TP. Convulsive disorders: toxicity of anticonvulsants. Clin Pharmacol 1991; 14:97.
Wisner KL, Perel JM. Serum levels of valproate and carbamazepine in breastfeeding mother-infant
pairs. J Clin Psychopharmacol 1998; 18:167.
Карбамазепин
Применение при биполярном расстройстве
Lusznat RM, Murphy DP, Nunn CMH. Carbamazepine vs. lithium in the treatment and prophylaxis of
mania. Br J Psychiatry 1986; 153:198.
Placidi GF, Lenzi A, Lazzerini F, et al. The comparative efficacy and safety of carbamazepine versus
lithium: a randomized double-blind three-year trial in 83 patients. J Clin Psychiatry 1986; 47:490.
Small JG, Klapper MH, Milstein V, et al. Carbamazepine compared with lithium in the treatment of
mania. Arch Gen Psychiatry 1991; 48:915.
Stuppaeck C, Barnas C, Miller C, et al. Carbamazepine in the prophylaxis of mood disorders. J Clin
Psychopharmacol 1990; 10:39.
Применение при других психических заболеваниях
Malcolm R, Ballenger JC, Sturgis ET, et al. Double-blind controlled trial comparing carbamazepine to
oxazepam treatment of alcohol withdrawal. Am J Psychiatry 1989; 146:617.
Schweizer E, Rickels K, Case WG, et al. Carbamazepine treatment in patients discontinuing long-term
benzodiazepine therapy. Arch Gen Psychiatry 1991; 48:448.
Sramek J, Herrera J, Costa J, et al. A carbamazepine trial in chronic treatment refractory schizophrenia.
Am J Psychiatry 1988; 145:748.
Uhde TW, Stein MB, Post RM. Lack of efficacy of carbamazepine in the treatment of panic disorder.
Am J Psychiatry 1988; 145:1104.
Побочные и токсические эффекты
Hart RG, Easton JD. Carbamazepine and hematological monitoring. Ann Neurol 1982; 11:309.
Heh CWC, Sramek J, Herrera J, et al. Exacerbation of psychosis after discontinuation of carbamazepine
treatment. Am J Psychiatry 1988; 145:878.
Joffe RT, MacDonald C, Kutcher SP. Lack of differential cognitive effects of lithium and
carbamazepine in bipolar affective disorder. J Clin Psychopharmacol 1988; 8:425.
Joffe RT, Post RM, Roy-Byrne PP, et al. Hematological effects of carbamazepine in patients with
affective illness. Am J Psychiatry 1985; 142:1196.
Roy-Byrne PP, Joffe RT, Uhde TW, et al. Carbamazepine and thyroid function in affectively ill patients.
Arch Gen Psychiatry 1984; 41:1150.
Trimble MR, Thompson PJ. Anticonvulsant drugs, cognitive function, and behavior. Epilepsia 1983;
24(suppl 1):55.
Лекарственные взаимодействия
Hosted by uCoz